Home » Giovanni Bader MD, PhD
Informazioni Generali
Medico specializzato in Endocrinologia e Malattie del Ricambio con esperienza in ambito clinico (indirizzo metabolico cardiovascolare e geriatrico) e dell’industria farmaceutica dove ha ricoperto incarichi di responsabilita’ di ricerca sui farmaci per il diabete
Esperienza
-
Novartis AG (CH)
Global Medical Head Cardiovascular and Metabolism
June 2010 – Feb 2023
-
GSK Italy
Therapeutic Area Head CVM
May 2007 – May 2010
-
Pfizer
HEOR Manager
Mar 2000 – Apr 2007
Educazione
-
Molecular Disease Branch, NHLBI, NIH, Bethesda US
Fellow
Jan 1995 – Dec 1997
-
Biochemistry Department, Uni Graz, Austria
Fellow
Mar 1992 – Apr 1994
-
Università di Sassari
PhD Fisiopatologia Medica
Jan 1994 – Dec 1998
-
Università di Ferrara
Specializzazione Endocrinologia e Metabolismo
Jan 1988 – Mar 1993
-
Università di Ferrara
Laurea in Medicine e Chirurgia
Jan 1981 – Dec 1987
Expertise
Awards & Publications
Beta-cell function in treatment-naïve patients with type 2 diabetes mellitus: Analyses of baseline data from 15 clinical trials
Matthias Blüher, Ankur Malhotra, Giovanni Bader
Diabetes Obes Metab. 2023;1–5.
The societal impact of early intensified treatment in patients with type 2 diabetes mellitus
F Tsotra, M Kappel, P Peristeris, G Bader, E Levi, N Lister, A Malhotra, …
Journal of Comparative Effectiveness Research, 00-00,2022
Clinically relevant predictors of cardiovascular events in patients with type 2 diabetes: a pooled analysis from clinical studies
A Malhotra, G Bader
DIABETOLOGIA 65 (SUPPL 1), S296-S296,2022
748-P: Clinically Relevant Predictors of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Pooled Analysis from Clinical Studies
A MALHOTRA, G BADER
Diabetes 71 (Supplement_1),2022
749-P: Clinically Relevant Predictors of Cardiovascular Events: Exploratory Analysis from the VERIFY Study of Initial Treatment of Type 2 Diabetes Mellitus
DR MATTHEWS, S DEL PRATO, PM PALDANIUS, G BADER